Ozempic is a medication used for the treatment of type 2 diabetes. It is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps to lower blood sugar levels by stimulating insulin release and reducing the production of glucagon, a hormone that raises blood sugar levels [1].

As for our tool, we are an AI language model developed by OpenAI. We are designed to provide comprehensive and informative answers to a wide range of questions based on the information available on the internet. Our responses are generated using a combination of natural language processing and machine learning algorithms, and we strive to provide accurate and helpful information to the best of our abilities.

Cited Sources:
[1] Drug Patent Watch. (n.d.). Ozempic. Retrieved from https://www.drugpatentwatch.com/p/tradename/OZEMPIC
[2] NovoCare. (n.d.). Ozempic Cost Navigator. Retrieved from https://www.novocare.com/diabetes/products/ozempic/cost-navigator.html
[3] NovoMedLink. (n.d.). Ozempic Cost and Coverage. Retrieved from https://www.novomedlink.com/diabetes/products/treatments/ozempic/cost-and-coverage.html